Table of Contents Table of Contents
Previous Page  116-117 / 956 Next Page
Information
Show Menu
Previous Page 116-117 / 956 Next Page
Page Background

Stokley S, et al. Human Papillomavirus Vaccination Coverage Among

Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–

2014, United States.

MMWR

. 2014;63(29);620-4.

http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6329a3.htm

Siegrist CA, et al. Human papilloma virus immunization in adolescent and young

adults: a cohort study to illustrate what events might be mistaken for adverse

reactions.

Pediatr Infect Dis J

. 2007;26(11):979-84.

http://www.ncbi.nlm.nih.gov/pubmed/17984802

y

http://www.medscape.com/viewarticle/565849

Vichnin M, et al. An Overview of Quadrivalent Human Papillomavirus Vaccine

Safety: 2006 to 2015.

Pediatr Infect Dis J

. 2015;34(9):983-91.

http://www.ncbi.nlm.nih.gov/pubmed/26107345

Macartney KK, et al. Safety of human papillomavirus vaccines: a review.

Drug

Saf

. 2013;36(6):393-412.

http://www.ncbi.nlm.nih.gov/pubmed/23637071

Stillo M, et al. Safety of human papillomavirus vaccines: a review.

Expert Opin

Drug Saf

. 2015;14(5):697-712.

http://www.ncbi.nlm.nih.gov/pubmed/25689872

EMA

. Assessment report. Human papillomavirus (HPV) vaccines. 11 / nov, 2015.

http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_docume nt/HPV_vaccines_20/Opinion_provided_by_Committee_for_Medicinal_Produc ts_for_Human_Use/WC500197129.pdf